The fact that NO is able to inhibit the canonical WNT-pathway in different tumor cells [42-44] including prostate cancer cells (as seen in this study) offers a more intriguing explanation for the massive down regulation of AR and AR-V in 22Rv1 cells. This evidence concerns the gene AR and prostate cancer.